{
    "eid": "2-s2.0-85116855300",
    "title": "Long-term results of hypofractionation with concomitant boost in patients with early breast cancer: A prospective study",
    "cover-date": "2021-10-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Multidisciplinary",
            "@code": "1000",
            "@abbrev": "MULT"
        }
    ],
    "keywords": [],
    "authors": [
        "Kitwadee Saksornchai",
        "Thitiporn Jaruthien",
        "Chonnipa Nantavithya",
        "Kanjana Shotelersuk",
        "Prayuth Rojpornpradit"
    ],
    "citedby-count": 2,
    "ref-count": 39,
    "ref-list": [
        "Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer",
        "Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients",
        "Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol",
        "Twenty-five year results of the national cancer institute randomized breast conservation trial",
        "Breast conserving therapy versus mastectomy for stage I\u2013II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial",
        "Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer",
        "Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials",
        "Radiotherapy after breast-preserving surgery in women with localized cancer of the breast",
        "Long-term results of hypofractionated radiation therapy for breast cancer",
        "The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial",
        "Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials",
        "The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial",
        "The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials",
        "Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial",
        "Ten-year results of FAST: a randomized controlled trial of 5-fraction whole-breast radiotherapy for early breast cancer",
        "Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881\u201310882 trial",
        "Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial",
        "Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France",
        "Simultaneous integrated boost irradiation after breast-conserving surgery: physician-rated toxicity and cosmetic outcome at 30 months\u2019 follow-up",
        "Five-year local control in a phase II study of hypofractionated intensity modulated radiation therapy with an incorporated boost for early stage breast cancer",
        "Comparative acute toxicity from whole breast irradiation using 3-week accelerated schedule with concomitant boost and the 6.5-week conventional schedule with sequential boost for early-stage breast cancer",
        "Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial",
        "Skin toxicity and cosmesis after hypofractionated whole breast irradiation for early breast cancer",
        "Toxicity criteria of the group (RTOG) and the European organization for research and treatment of cancer (EORTC)",
        "Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I\u2013II breast cancer",
        "Boost in conservative treatment: 6 years results of randomized trial",
        "Randomized trial shows reduced whole breast dose negates benefit of lumpectomy radiotherapy boost",
        "The St George, Wollongong and Liverpool Breast Boost Trial: 1st planned analysis at 6-year mean follow-up",
        "Tumour bed boost radiotherapy for women after breast-conserving surgery",
        "Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue",
        "Phase I\u2013II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients",
        "Adjuvant hypofractionated radiotherapy with weekly concomitant boost for women with early breast cancer: the clinical experience at Genoa university",
        "Five-year results of a prospective case series of accelerated hypofractionated whole breast radiation with concomitant boost to the surgical bed after conserving surgery for early breast cancer",
        "Hypofractionation with simultaneous integrated boost for early breast cancer",
        "The IMPORT Trials are launched",
        "Simultaneous integrated boost: improving the patient journey during breast cancer radiotherapy safely",
        "Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Chulalongkorn University"
    ]
}